TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/29/2023
Back to search
Official data from USPTO
ENZO CLINICAL LABS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
ENZO CLINICAL LABS
ST13
US500000075741692Class
42
Filing
75741692
Registration
2350099
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
08/29/2023
Trademark type
Word
Nice classes
42
Filing date
06/25/1999
Registration date
05/16/2000
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/09/2020
Last transaction
08/29/2023
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
12/19/1994
First use in commerce
12/19/1994
Drawing code
1
Owner type
03
Owner location
BURLINGTON, NC, US
Examiner
LE, KHANH M
Law office
M50
Current location
GENERIC WEB UPDATE
Holders and representatives
Holders
LABORATORY CORPORATION OF AMERICA HOLDINGS
ENZO BIOCHEM, INC.
Representatives
William Bryner Kilpatrick Townsend & Stockton LLP
Technical classification
Nice Classes
Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
MEDICAL CLINICAL LABORATORIES
Publications
History of USPTO decisions and trademark events.
30 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/29/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/29/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
08/09/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
09/28/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
09/28/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
09/28/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
09/28/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
09/28/2022
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
06/09/2020
RNL2
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
06/09/2020
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
06/09/2020
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
06/07/2020
PR89
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
06/03/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
06/03/2020
E89R
TEAS SECTION 8 & 9 RECEIVED
03/20/2020
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
04/20/2010
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
04/20/2010
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/15/2010
E89R
TEAS SECTION 8 & 9 RECEIVED
04/05/2010
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
08/18/2006
815F
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
05/08/2006
E815
TEAS SECTION 8 & 15 RECEIVED
05/08/2006
CFIT
CASE FILE IN TICRS
03/31/2006
R.PR
REGISTERED-PRINCIPAL REGISTER
05/16/2000
PUBO
PUBLISHED FOR OPPOSITION
02/22/2000
NPUB
NOTICE OF PUBLICATION
01/21/2000
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/18/1999
CNEA
EXAMINER'S AMENDMENT MAILED
10/08/1999
DOCK
ASSIGNED TO EXAMINER
10/07/1999
Continuous trademark protection
Get notified about every new filing that threatens ENZO CLINICAL LABS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.